Trials / Completed
CompletedNCT00199602
Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients
Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients : Phase III Randomised Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 420 (actual)
- Sponsor
- University Hospital, Limoges · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase III open-labed, multicenter, prospective, randomised study, and comparative 3-arms of 140 patients (i.e. 420 total patients). Study period (date of first inclusion/last inclusion): 3 years Treatment period : 3 months
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | warfarine - low molecular heparin |
Timeline
- Start date
- 1999-08-01
- Primary completion
- 2009-12-01
- Completion
- 2010-12-01
- First posted
- 2005-09-20
- Last updated
- 2018-08-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00199602. Inclusion in this directory is not an endorsement.